Maximum quantity allowed is 999
Please select the quantity
CAS RN: 13614-98-7 | Product Number: M2288
Minocycline Hydrochloride
Purity: >98.0%(T)(HPLC)
Synonyms:
Product Documents:
* Available Stock: Prompt shipment (for products) in Saitama/Hyogo warehouse. Stock In Other WH: Shipment in about 2-3 Business Days from Saitama warehouse. Please contact us
if you need further information.
* The displayed price is the unit price and does not include consumption tax. The unit prices displayed are the latest and are subject to change without notice.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* The displayed price is the unit price and does not include consumption tax. The unit prices displayed are the latest and are subject to change without notice.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | M2288 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__2__3H__2__7N__3O__7·HCl = 493.94 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Condition to Avoid | Heat Sensitive |
Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image) |
CAS RN | 13614-98-7 |
Related CAS RN | 10118-90-8 |
Reaxys Registry Number | 4836328 |
PubChem Substance ID | 160871228 |
Merck Index (14) | 6202 |
MDL Number | MFCD00083669 |
Specifications
Appearance | Light yellow to Yellow to Green powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 %(calcd.on anh.substance) |
Specific rotation [a]20/D | -170 to -180 deg(C=0.5、0.1mol/L HCl) |
Water | 4.3 to 8.0 % |
Properties (reference)
Specific Rotation | -175° (C=0.5,0.1mL/L HCl) |
Solubility in water | Slightly soluble |
Solubility (soluble in) | Methanol, Dimethylformamide |
GHS
Pictogram | |
Signal Word | Danger |
Hazard Statements | H360 : May damage fertility or the unborn child. H362 : May cause harm to breast-fed children. H317 : May cause an allergic skin reaction. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P263 : Avoid contact during pregnancy/ while nursing. P272 : Contaminated work clothing should not be allowed out of the workplace. P260 : Do not breathe dusts or mists. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P362 + P364 : Take off contaminated clothing and wash it before reuse. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. P405 : Store locked up. |
Related Laws:
RTECS# | QI7630500 |
Transport Information:
Application
Studies on Antibiotic Activity
References
- The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin
- Neuroprotective and anti-human immunodeficiency virus activity of minocycline
Application
Neuroprotective Studies
References
- Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
- Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
- A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window
- Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
PubMed Literature
Articles/Brochures
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.